Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, M ichigan 48109 , USA.
Am J Gastroenterol. 2012 Feb;107(2):247-52. doi: 10.1038/ajg.2011.314. Epub 2011 Sep 20.
Early rehospitalizations have been well characterized in many disease states, but not among patients with cirrhosis. The aims of this study were to identify the frequency, costs, predictors, and preventable causes of hospital readmissions among patients with decompensated cirrhosis.
Rates of readmission were calculated for 402 patients discharged after one of the following complications of cirrhosis: ascites, spontaneous bacterial peritonitis, renal failure, hepatic encephalopathy, or variceal hemorrhage. Costs of readmissions were calculated using the hospital accounting system. Predictors of time to first readmission were determined using Cox regression, and predictors of hospitalization rate/person-years were determined using negative binomial regression. The independent association between readmission rate and mortality was determined using Cox regression. Admissions within 30 days of discharge were assessed by two reviewers to determine if preventable.
Overall, 276 (69%) subjects had at least one nonelective readmission, with a median time to first readmission of 67 days. By 1 week after discharge, 14% of subjects had been readmitted, and 37% were readmitted within 1 month. The mean costs for readmissions within 1 week and between weeks 1 and 4 were $28,898 and $20,581, respectively. During a median follow-up of 203 days, the median number of readmissions was 2 (range 0-40), with an overall rate of 3 hospitalizations/person-years. Patients with more frequent readmissions had higher risk of subsequent mortality, despite adjustment for confounders including the Model for End-stage Liver Disease (MELD) score. Predictors of time to first readmission included MELD score, serum sodium, and number of medications on discharge; predictors of hospitalization rate included these variables as well as the number of cirrhosis complications and being on the transplant list at discharge. Among 165 readmissions within 30 days, 22% were possibly preventable.
Hospital readmissions among patients with decompensated cirrhosis are common, costly, moderately predictable, in some cases, possibly preventable, and independently associated with mortality. These findings support the development of disease management interventions to prevent rehospitalization.
许多疾病状态下的早期再入院情况已得到充分描述,但肝硬化患者除外。本研究旨在确定失代偿期肝硬化患者的再入院频率、费用、预测因素和可预防的原因。
对 402 名因肝硬化以下并发症出院的患者进行再入院率计算:腹水、自发性细菌性腹膜炎、肾衰竭、肝性脑病或静脉曲张出血。使用医院会计系统计算再入院费用。使用 Cox 回归确定首次再入院时间的预测因素,使用负二项回归确定住院率/人年的预测因素。使用 Cox 回归确定再入院率与死亡率之间的独立关联。通过两位评审员评估出院后 30 天内的入院情况,以确定是否可以预防。
总体而言,276 名(69%)患者至少有一次非选择性再入院,首次再入院的中位时间为 67 天。出院后 1 周内,14%的患者再次入院,37%的患者在 1 个月内入院。出院后 1 周内和 1-4 周内的再入院费用分别为 28898 美元和 20581 美元。在中位随访 203 天期间,再入院中位数为 2 次(范围 0-40 次),总体住院率为 3 次/人年。尽管调整了包括终末期肝病模型(MELD)评分在内的混杂因素,但再入院次数较多的患者随后的死亡率风险更高。首次再入院时间的预测因素包括 MELD 评分、血清钠和出院时的药物数量;住院率的预测因素包括这些变量以及肝硬化并发症的数量和出院时是否在移植名单上。在 30 天内的 165 次再入院中,22%可能是可以预防的。
失代偿期肝硬化患者的医院再入院情况很常见,费用高,在某些情况下可预测,有些情况下可能是可以预防的,且与死亡率独立相关。这些发现支持开发疾病管理干预措施以预防再入院。